[ET Net News Agency, 16 September 2024] HSBC Global Research lowered the target price
for Tigermed (03347) to HKD46.2 from HKD69.1 and maintained the "buy" rating.
The research house said it expects a 2023-26 recurring net profit CAGR of 8%, with solid
order bookings and improving gross margins (GPM). (rc)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
37.850 -0.300 (-0.786%) Others
16/09/2024 14:50
{I-bank focus}HSBC lowers Tigermed (03347) to HKD46.2
Previous︰27/09/2024 11:09 {Hot Stocks}TIGERMED(03347) quoted at HK$34, up 9.5%
Next︰16/09/2024 08:45 Summary of listed companies announcements (10)
02/10/2024 09:43 {Hot Stocks}6 HK MMA stocks of price swing at 9:42am
30/09/2024 10:32 {Hot Stocks}2 listed firms see price swing at 10:31am
30/09/2024 08:45 Summary of listed companies announcements (17)
05/09/2024 08:45 Summary of listed companies announcements (7)
30/08/2024 08:45 Summary of listed companies announcements (18)
| Remark: | Real time quote last updated: 08/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |